日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Adjunctive pharmacological strategies for residual risk reduction after myocardial revascularisation

心肌血运重建术后降低残余风险的辅助药物治疗策略

Oshima, Asahi; Serruys, Patrick W; Garg, Scot; McEvoy, J William; Wood, David A; Doenst, Torsten; Taggart, David P; Puskas, John D; Shajahan, Ajmal; Sharif, Faisal; Miyashita, Kotaro; Tobe, Akihiro; Tsai, Tsung-Ying; Revaiah, Pruthvi C; Dunne, Fidelma; Mehran, Roxana; Budoff, Matthew J; Kastelein, John J; Stroes, Eric S G; Khamis, Ramzi; Koenig, Wolfgang; Onuma, Yoshinobu

The trajectory of fatigue over time in breast cancer patients treated with chemotherapy: exploring the effect of anthracycline-based chemotherapy

乳腺癌化疗患者疲劳随时间变化的轨迹:探讨蒽环类化疗的影响

Kastelein, Anneke; Kervezee, Laura; Mink van der Molen, Dieuwke R; Evers, Daniel J; van der Pol, Carmen C; Doeksen, Annemiek; Chavannes, N H; Gelderblom, Hans; Neefjes, Jacques; Verkooijen, Helena M; May, Anne M

Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular disease

强效胆固醇酯转移蛋白抑制剂奥比塞曲匹对心血管疾病患者p-tau217水平的影响

Davidson, Michael H; Szarek, Michael; Scheltens, Philip; Vijverberg, Everard; Hsieh, Andrew; Ditmarsch, Marc; Kling, Douglas; Curcio, Danielle; Nicholls, Stephen J; Ray, Kausik K; Cummings, Jeffrey L; Kastelein, John Jp

The emerging role of CETP inhibition in the prevention of Alzheimer's disease

CETP抑制在预防阿尔茨海默病中的新兴作用

Davidson, Michael H; Hsieh, Andrew; de Kleer, Mathijs; Szarek, Michael S; Scheltens, Philip; Vijverberg, Everard; Johnson, Adam; Ditmarsch, Marc; Kastelein, John J P

Novel cholesterol lowering drugs: Can phase 2/3 clinical trial safety assessments predict cardiovascular event outcome trial efficacy?

新型降胆固醇药物:2/3期临床试验安全性评估能否预测心血管事件结果试验疗效?

Shear, Charles; Davidson, Michael H; Ditmarsch, Marc; Kastelein, John J P; Szarek, Michael

RNA interference versus antibody-based PCSK9 inhibition for the prevention of cardiovascular disease: a drug-target Mendelian randomization study

RNA干扰与基于抗体的PCSK9抑制剂在预防心血管疾病中的比较:一项药物靶点孟德尔随机化研究

Gagnon, Eloi; Gill, Dipender; Bourgault, Jérôme; Gobeil, Émilie; Mitchell, Patricia L; Girard, Arnaud; Paulin, Audrey; Couture, Christian; Bossé, Yohan; Thériault, Sébastien; Mathieu, Patrick; Vohl, Marie-Claude; Tchernof, André; Ray, Kausik K; Kastelein, John J P; Arsenault, Benoit J

The Impact of Chemotherapy and Body Mass Index on Cancer-Related Fatigue in Colon Cancer Patients: A PROFILES-Registry Study

化疗和体重指数对结肠癌患者癌症相关疲乏的影响:一项PROFILES注册研究

Kastelein, Anneke; Mols, Floortje; Kervezee, Laura; Chavannes, Niels H; Gelderblom, Hans; Neefjes, Jacques; Hinnen, Chris

Association Between Lipoprotein(a) and Arterial Stiffness in Young Adults with Familial Hypercholesterolemia

家族性高胆固醇血症青年患者脂蛋白(a)与动脉硬化的关系

van den Bosch, Sibbeliene E; Boer, Lotte M de; Revers, Alma; Schrauben, Eric M; Ooij, Pim van; Nederveen, Aart J; Corpeleijn, Willemijn E; Kastelein, John J P; Wiegman, Albert; Hutten, Barbara A

Author Correction: The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial

作者更正:FGF21类似物pegozafermin治疗重度高甘油三酯血症:一项随机II期试验

Bhatt, Deepak L; Bays, Harold E; Miller, Michael; Cain, James E 3rd; Wasilewska, Katarzyna; Andrawis, Nabil S; Parli, Teresa; Feng, Shibao; Sterling, Lulu; Tseng, Leo; Hartsfield, Cynthia L; Agollah, Germaine D; Mansbach, Hank; Kastelein, John J P

Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a Mendelian randomization analysis

胆固醇酯转移蛋白 (CETP) 活性降低与痴呆风险:一项孟德尔随机化分析

Schmidt, Amand F; Davidson, Michael H; Ditmarsch, Marc; Kastelein, John J; Finan, Chris